Home » Topics » Regulatory » Patents

Patents
RSS

Novel immunomodulatory agents described by Takeda

March 12, 1998

Antithrombotics developed at Warner-Lambert

March 12, 1998

New antitumor and immunosuppressive compounds in development at Klinge

March 12, 1998

Rhone-Poulenc Rorer synthesizes and evaluates new TNF/cAMP PDE inhibitors

March 12, 1998

P&U scientists disclose new MMP inhibitors for connective tissue diseases

March 12, 1998

Inhibitors of cholesterol biosynthesis under study at Pfizer

March 11, 1998

Antimigraine agent for nasal or oral administration disclosed by Pierre Fabre

March 11, 1998

SmithKline Beecham claims indolines for CNS disorders

March 11, 1998

Allergan develops retinoid-like compounds

March 11, 1998

New potassium channel activators from American Home

March 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...